Senseonics to Announce Q3 2025 Results Discuss on Call

Author: Logan Wright Updated: 10-22-2025 04:20 PM

Senseonics Holdings, Inc. Prepares for Q3 2025 Earnings Release

Senseonics Holdings, Inc. (NYSE American: SENS), a leader in medical technology dedicated to advancing glucose monitoring solutions, is poised to release its financial results for the third quarter of 2025. This announcement is slated to occur after market close on a date in early November. The third quarter earnings report will provide critical insights into the company’s performance and its ongoing commitment to improving diabetes management.

Conference Call Details

Following the release of the financial results, there will be a live conference call dedicated to discussing Senseonics' performance during the third quarter. This event is scheduled to commence at 4:30 P.M. Eastern Time on the same day as the earnings announcement. Investors and stakeholders will be able to join the conference call by dialing specific numbers well before the start time, ensuring everyone can participate in the conversation.

Joining the Conference Call

To access the conference call, interested parties can dial in using numbers provided by the company, which include options for both US/Canada and international participants. A passcode will be required for entry, allowing the company’s management to share their insights directly with stockholders and analysts.

Future of Diabetes Management with Senseonics

Senseonics continues to innovate within the diabetes care sector through its commitment to long-term glucose monitoring solutions. Their flagship products, the Eversense 365 and Eversense E3, demonstrate their advanced technology with a smart transmitter that seamlessly communicates with a smartphone app. This integration of technology not only assists patients in monitoring their glucose levels but aims to enhance the quality of life for those living with diabetes.

About Senseonics Holdings, Inc.

As a pioneering medical technology company, Senseonics focuses on the design and manufacturing of long-term implantable systems for continuous glucose monitoring. Their initiatives aim to transform the diabetes management landscape by offering patients a more reliable method of monitoring glucose levels with minimal intrusion. The company's aspiration is to empower users with timely and accurate data essential for making informed health decisions.

Contact Information

For investor inquiries regarding Senseonics, interested individuals can reach out to the designated Investor Relations contact. Jeremy Feffer of LifeSci Advisors serves as the primary contact for investment-related questions and can be reached through the company's official email.

Frequently Asked Questions

What is the purpose of the conference call?

The conference call is intended to discuss Senseonics' financial performance for the third quarter and provide insights into company strategies and future directions.

How can I listen to the conference call?

Participants can listen to the conference call by dialling the telephone numbers provided in the earnings release, using a specific passcode for access.

What products does Senseonics offer?

Senseonics offers continuous glucose monitoring systems, specifically the Eversense 365 and Eversense E3 models, designed for long-term use.

What are the benefits of the Eversense CGM systems?

The Eversense systems provide real-time glucose level data sent directly to a smartphone app, enabling users to manage their diabetes more effectively.

Who can I contact for more information about the company?

For more information, investors can reach out to Jeremy Feffer of LifeSci Advisors via the company email provided in press releases.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.